Page last updated: 2024-10-31

mitoxantrone and Respiratory Distress Syndrome

mitoxantrone has been researched along with Respiratory Distress Syndrome in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"Acute airway obstruction caused by mucoid impaction can cause sometimes life-threatening respiratory distress."1.33[Acute airway obstruction during chemotherapy-induced agranulocytosis with fever]. ( Bernardin, G; Burel-Vandenbos, F; Deswardt, P; Hyvernat, H; Vandenbos, F, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vandenbos, F1
Deswardt, P1
Hyvernat, H1
Burel-Vandenbos, F1
Bernardin, G1

Other Studies

1 other study available for mitoxantrone and Respiratory Distress Syndrome

ArticleYear
[Acute airway obstruction during chemotherapy-induced agranulocytosis with fever].
    Revue de pneumologie clinique, 2006, Volume: 62, Issue:1

    Topics: Agranulocytosis; Airway Obstruction; Antineoplastic Combined Chemotherapy Protocols; Bronchitis; Cyt

2006